This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: **Fridtjof Schroder: A Pioneer in Peptide Compounds**
Introduction
Fridtjof Schroder is a distinguished inventor based in Berlin, Germany, renowned for his contributions to the field of peptide compounds. With a noteworthy patent to his name, he has made significant strides in pharmaceutical innovation.
Latest Patents
Fridtjof Schroder holds a patent for peptide compounds, specifically LHRH-antagonists. This groundbreaking invention has the potential to impact the treatment of various medical conditions, showcasing Schroder's expertise and commitment to advancing science.
Career Highlights
Currently, Fridtjof Schroder is employed at Schering Aktiengesellschaft, a prominent pharmaceutical company where he continues to push the boundaries of medical research and innovation. His work at Schering highlights his dedication to developing effective solutions for healthcare challenges.
Collaborations
Throughout his career, Schroder has collaborated with notable colleagues such as Paul Thamm and Alessandro Lobbia. These collaborations have facilitated the exchange of ideas and expertise, enhancing the overall impact of their collective innovations in the field.
Conclusion
Fridtjof Schroder's contributions to the realm of peptide compounds exemplify the spirit of innovation. His patent for LHRH-antagonists, alongside his collaborative efforts at Schering Aktiengesellschaft, underscores the importance of teamwork in achieving significant advancements in healthcare and pharmaceutical sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile